Ireland has introduced legislation that would allow community pharmacists to renew eligible contraception prescriptions, marking a proposed expansion of pharmacy-led care and medicines access services.

The Health (Provision of Contraception Prescribing Service in Retail Pharmacy Businesses) Bill 2026 would enable women aged 17 and over to renew prescriptions for short-acting contraceptives directly through participating pharmacies rather than returning to a GP for each renewal.

According to Euractiv Advocacy Lab, the proposal covers short-acting methods including the oral contraceptive pill, transdermal patch and vaginal ring.

Under the proposed framework, women eligible under Ireland’s Free Contraception Scheme, currently those aged 17 to 35, would continue to receive services without charge, while women outside the scheme would pay a locally determined fee.

The legislation would amend the Health Act 1970, the Irish Medicines Board Act 1995 and the Pharmacy Act 2007 to establish the legal basis for the service.

Clinical protocols outlined in the proposal would continue to require periodic GP review depending on patient age and clinical circumstances. Higher-risk patients and those better suited to long-acting reversible contraception would remain under medical supervision through existing care pathways.

The proposal also arrives amid discussion around expanding the Free Contraception Scheme beyond its current upper age limit of 35. Government estimates indicate extending eligibility to women aged 36 to 40 could require additional annual funding.

If enacted, the legislation would still require completion of the parliamentary process alongside the development of clinical guidance, training frameworks and operational measures before implementation.

The proposal signals continued movement towards broader use of community pharmacy services within Ireland’s healthcare delivery model while seeking to improve access and reduce pressure across primary care settings.